OWIM
ODT

Old West Investment Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Old West Investment Management’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,763
Closed -$321K – 74
2020
Q4 		$321K Sell
16,763
-889
-5% -$13.7K 0.07% 48
2020
Q3 		$237K Buy
17,652
+7,121
+68% +$202K 0.05% 47
2020
Q2 		$445K Sell
10,531
-61
-0.6% -$1.97K 0.13% 45
2020
Q1 		$292K Sell
10,592
-1,038
-9% -$30.3K 0.22% 47
2019
Q4 		$377K Hold
11,630
– – 0.14% 55
2019
Q3 		$302K Sell
11,630
-1,944
-14% -$65.1K 0.18% 54
2019
Q2 		$498K Sell
13,574
-46
-0.3% -$1.1K 0.23% 56
2019
Q1 		$301K Buy
13,620
+497
+4% +$8.69K 0.11% 62
2018
Q4 		$184K Sell
13,123
-1,015
-7% -$15.8K 0.05% 67
2018
Q3 		$274K Buy
+14,138
New +$288K 0.11% 68

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Old West Investment Management's ODT Position: Q1 2021 in Review

Old West Investment Management sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2021, closing a stake of 16,763 shares — an estimated $321K sold.

Old West Investment Management first reported a position in ODT in Q3 2018 and held it in 10 quarters. The position peaked at $498K in Q2 2019. 83 funds tracked by Wall St. Rank hold ODT as of Q1 2021.

  • Old West Investment Management reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Old West Investment Management sold 16,763 Odonate Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $321K.
  • Old West Investment Management first reported a position in Odonate Therapeutics, Inc. Common Stock in Q3 2018 and held it in 10 quarters.
  • Old West Investment Management's Odonate Therapeutics, Inc. Common Stock position peaked at $498K in Q2 2019.
  • 83 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Old West Investment Management's 13F filing for Q1 2021, filed 14 May 2021.